Page last updated: 2024-08-21

ethambutol and AIDS Seroconversion

ethambutol has been researched along with AIDS Seroconversion in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (50.00)18.2507
2000's3 (13.64)29.6817
2010's7 (31.82)24.3611
2020's1 (4.55)2.80

Authors

AuthorsStudies
Crook, AM; Dawson, R; Diacon, AH; Gillespie, SH; McHugh, TD; Mendel, CM; Meredith, SK; Mohapi, L; Murphy, ME; Nunn, AJ; Phillips, PPJ; Singh, KP; Spigelman, M; Tweed, CD1
Andrade, BB; Arriaga, MB; Calvacante, S; Cordeiro-Santos, M; Durovni, B; Figueiredo, MC; Kritski, A; Peetluk, LS; Rebeiro, PF; Rolla, VC; Sterling, TR; Turner, MM1
Amukoye, EI; Crook, AM; Dawson, R; Diacon, AH; Gillespie, SH; Hanekom, M; McHugh, TD; Mendel, CM; Meredith, SK; Murphy, ME; Murthy, SE; Nunn, AJ; Phillips, PPJ; Singh, KP; Spigelman, M; Tweed, CD; Wills, GH1
Crook, AM; Gillespie, SH; McHugh, TD; Mendel, CM; Meredith, SK; Murray, SR; Nunn, AJ; Pappas, F; Phillips, PP1
Bateson, AL; Butcher, PD; Charalambous, S; Churchyard, GJ; Clouting, HE; Coleman, D; Geldenhuys, H; Harrison, TS; Hatherill, M; Jindani, A; Magweta, L; McHugh, TD; McIlleron, HM; Mitchison, DA; Mungofa, S; Nunn, AJ; Nyirenda, S; Phillips, PP; Shah, NA; Shepherd, J; van Dijk, JH; Zizhou, S; Zvada, SP1
Asres, A; Deressa, W; Jerene, D1
Khajotia, R; Manthari, K1
Anand, A; Datye, AS; Inamdar, V; Iyer, R; Kale, V; Kanoj, DM; Khillare, KM; Manoj, MM; Pereira, M; Risbud, AR; Thakar, M; Tripathy, S1
Menzies, D; Parisien, I; Pelletier, M; Rocher, I; Valiquette, C; Yee, D1
Bhagavathy, S; Gayathri, TN; Gurumurthy, P; Venkatesan, P1
Batchelor, B; Brindle, R; Gathua, S; Gilks, C; Githui, W; Godfrey-Faussett, P; Hawken, M; Morris, J; Nunn, P; Odhiambo, J1
Fox, R; Gillespie, SH; Kennedy, N; Kisyombe, GM; Ngowi, FI; Ramsay, AR; Saruni, AO; Uiso, LO1
Bonk, S; Bromberg, A; Bromberg, R; Hanna, BA; Neville, K; Rom, WN1
Bergmann, F; Fehrenbach, J; Jautzke, G; Mauch, H; Ruf, B; Schürmann, D1
Delaney, V; Hong, JH; Sommer, B; Sumrani, N1
Brook, MG; Miller, RF1
Cameron, DW; Gallicano, K; Garber, G; Oliveras, L; Rachlis, A; Sahai, J; Seguin, I; Swick, L; Tailor, S; Walker, S1
Mitchison, DA1
Chagaluka, S; Drobniewski, F; Fine, PE; Glynn, JR; Jenkins, PA; Ngwira, B; Pönnighaus, JM; Warndorff, DK; Yates, M1
Nolan, CM1

Reviews

2 review(s) available for ethambutol and AIDS Seroconversion

ArticleYear
Prevention and management of tuberculosis in HIV positive patients living in countries with a low prevalence of Mycobacterium tuberculosis.
    Genitourinary medicine, 1996, Volume: 72, Issue:2

    Topics: Antitubercular Agents; Cross Infection; Emigration and Immigration; Ethambutol; HIV Seropositivity; Humans; Isoniazid; Patient Isolation; Prevalence; Tuberculin Test; Tuberculosis; United Kingdom

1996
Failure of therapy for tuberculosis in human immunodeficiency virus infection.
    The American journal of the medical sciences, 1992, Volume: 304, Issue:3

    Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Pyridoxine; Rifampin; Tuberculosis

1992

Trials

4 trial(s) available for ethambutol and AIDS Seroconversion

ArticleYear
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status.
    BMC pulmonary medicine, 2019, Aug-14, Volume: 19, Issue:1

    Topics: Adult; Antitubercular Agents; Ethambutol; Female; HIV Seropositivity; Humans; Incidence; Isoniazid; Linear Models; Male; Multivariate Analysis; Prospective Studies; Pyrazinamide; Rifampin; Risk Factors; Treatment Outcome; Tuberculosis, Pulmonary; United Kingdom

2019
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
    The New England journal of medicine, 2014, Oct-23, Volume: 371, Issue:17

    Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; HIV Seropositivity; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult

2014
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.
    The New England journal of medicine, 2014, Oct-23, Volume: 371, Issue:17

    Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; HIV Seropositivity; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult

2014
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
    The American review of respiratory disease, 1993, Volume: 148, Issue:6 Pt 1

    Topics: Adult; Aged; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; HIV-1; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary

1993

Other Studies

16 other study(ies) available for ethambutol and AIDS Seroconversion

ArticleYear
Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis.
    The Journal of infectious diseases, 2020, 04-07, Volume: 221, Issue:9

    Topics: Adult; Antitubercular Agents; Brazil; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Weight Gain

2020
Toxicity associated with tuberculosis chemotherapy in the REMoxTB study.
    BMC infectious diseases, 2018, 07-11, Volume: 18, Issue:1

    Topics: Adult; Antitubercular Agents; Clinical Protocols; Ethambutol; Female; HIV Seropositivity; Humans; Incidence; Isoniazid; Male; Moxifloxacin; Treatment Outcome; Tuberculosis, Pulmonary

2018
Tuberculosis treatment outcomes of six and eight month treatment regimens in districts of Southwestern Ethiopia: a comparative cross-sectional study.
    BMC infectious diseases, 2016, 11-08, Volume: 16, Issue:1

    Topics: Adult; Antitubercular Agents; Cross-Sectional Studies; Drug Therapy, Combination; Ethambutol; Ethiopia; Female; HIV Seropositivity; Hospitals; Humans; Isoniazid; Logistic Models; Male; Rifampin; Socioeconomic Factors; Treatment Outcome; Tuberculosis

2016
An apparently healthy young man with a peculiar-looking chest radiograph.
    Canadian family physician Medecin de famille canadien, 2011, Volume: 57, Issue:3

    Topics: Adult; Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Fever; HIV Seropositivity; Humans; Isoniazid; Male; Pleural Effusion; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Pulmonary; Young Adult

2011
Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India.
    The Indian journal of medical research, 2011, Volume: 133

    Topics: Adult; Antitubercular Agents; Communicable Disease Control; Directly Observed Therapy; Enzyme-Linked Immunosorbent Assay; Ethambutol; HIV Seronegativity; HIV Seropositivity; Humans; India; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary

2011
Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis.
    American journal of respiratory and critical care medicine, 2003, Jun-01, Volume: 167, Issue:11

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Ethambutol; Female; HIV Seropositivity; Humans; Incidence; Isoniazid; Male; Middle Aged; Proportional Hazards Models; Pyrazinamide; Rifampin; Risk Factors; Tuberculosis, Pulmonary

2003
Standardization of the method for estimation of ethambutol in pharmaceutical preparations and biological fluid.
    Indian journal of experimental biology, 2004, Volume: 42, Issue:1

    Topics: Antitubercular Agents; Chemistry, Clinical; Chromatography; Dose-Response Relationship, Drug; Ethambutol; HIV Seropositivity; Humans; Isoniazid; Pharmaceutical Preparations; Pyrazinamide; Reference Standards; Reproducibility of Results; Resins, Synthetic; Sensitivity and Specificity; Time Factors

2004
Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.
    Lancet (London, England), 1993, Aug-07, Volume: 342, Issue:8867

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Cohort Studies; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; HIV-1; Humans; Isoniazid; Kenya; Male; Recurrence; Risk Factors; Thioacetazone; Tuberculosis

1993
The third epidemic--multidrug-resistant tuberculosis.
    Chest, 1994, Volume: 105, Issue:1

    Topics: Adult; Age Factors; Comorbidity; Disease Outbreaks; Drug Resistance, Microbial; Ethambutol; Female; HIV Seropositivity; Humans; Ill-Housed Persons; Isoniazid; Male; Minority Groups; Mycobacterium tuberculosis; New York City; Rifampin; Sex Factors; Streptomycin; Substance Abuse, Intravenous; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Unemployment

1994
Acute and long-term efficacy of antituberculous treatment in HIV-seropositive patients with tuberculosis: a study of 36 cases.
    The Journal of infection, 1993, Volume: 26, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antitubercular Agents; Bisexuality; CD4-CD8 Ratio; Ethambutol; Female; HIV Seropositivity; Homosexuality; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Time Factors; Treatment Failure; Treatment Outcome; Tuberculosis

1993
Mycobacterial infections in renal allograft recipients.
    Transplantation proceedings, 1993, Volume: 25, Issue:3

    Topics: Drug Therapy, Combination; Ethambutol; HIV Seropositivity; Humans; Immunosuppressive Agents; Isoniazid; Kidney Transplantation; Mycobacterium Infections; New York; Postoperative Complications; Pyrazinamide; Rifampin; Transplantation, Homologous

1993
Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection.
    Annals of internal medicine, 1997, Aug-15, Volume: 127, Issue:4

    Topics: Adult; Aged; Antitubercular Agents; Case-Control Studies; Diarrhea; Ethambutol; Female; HIV Infections; HIV Seropositivity; Humans; Intestinal Absorption; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin

1997
How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1998, Volume: 2, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; HIV Seropositivity; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

1998
Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2000, Volume: 4, Issue:8

    Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Malawi; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant

2000
Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system--New York, 1991.
    MMWR. Morbidity and mortality weekly report, 1992, Jul-17, Volume: 41, Issue:28

    Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis

1992
From the Centers for Disease Control. Transmission of multidrug-resistant tuberculosis among immunocompromised persons, correctional system--New York, 1991.
    JAMA, 1992, Aug-19, Volume: 268, Issue:7

    Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis

1992